Department of Medicine, John H Stroger Hospital of Cook County, Chicago, Illinois.
Division of Cardiology, Rush University Medical Center, Chicago, Illinois.
Catheter Cardiovasc Interv. 2019 Nov 15;94(6):773-780. doi: 10.1002/ccd.28156. Epub 2019 Feb 21.
To define the national rate of complete heart block (CHB) after transcatheter aortic valve replacement (TAVR) and its impact on procedural mortality, overall cost, and length of hospital stay.
CHB leading to permanent pacemaker (PPM) implantation is one of the most common complications post TAVR. National data on the temporal trend of CHB post TAVR are lacking.
We queried the 2012-2014 National Inpatient Sample databases to identify all patients who underwent TAVR. Patients with preoperative pacemakers or implantable cardioverter-defibrillators were excluded. Association between CHB and outcomes, and overall trends in rate of CHB, PPM implantation, and inpatient mortality were examined.
Of 35,500 TAVR procedures, 3,675 (10.4%) had CHB. Overall, occurrence of CHB significantly increased from 8.4% in 2012 to 11.8% in 2014 (adjusted OR per year: 1.23; 95% confidence interval [CI]: 1.17-1.29, P trend <0.001). During the same period, PPM implantation increased from 9.5 to 13.7% (adjusted OR per year: 1.22; 95% CI: 1.16-1.28, P trend <0.001). Patients with CHB had higher odds of in-hospital mortality when compared to patients without CHB (5.9% vs. 4.2%, adjusted OR: 1.32; 95% CI: 1.12-1.56; p = 0.001). Moreover, CHB was also associated with longer length of stay (LOS) and higher hospitalization cost.
There was a significant increase in rates of CHB and PPM implantation over the study period. Development of CHB was associated with increased in-hospital mortality, LOS, and hospitalization cost.
定义经导管主动脉瓣置换术(TAVR)后完全性心脏阻滞(CHB)的全国发生率及其对手术死亡率、总费用和住院时间的影响。
CHB 导致永久性起搏器(PPM)植入是 TAVR 后最常见的并发症之一。缺乏 TAVR 后 CHB 的全国性时间趋势数据。
我们查询了 2012-2014 年全国住院患者样本数据库,以确定所有接受 TAVR 的患者。排除术前有起搏器或植入式心脏复律除颤器的患者。检查 CHB 与结局之间的关系,以及 CHB、PPM 植入和住院死亡率的总体趋势。
在 35500 例 TAVR 手术中,有 3675 例(10.4%)发生 CHB。总体而言,CHB 的发生率从 2012 年的 8.4%显著增加到 2014 年的 11.8%(每年调整后的 OR:1.23;95%置信区间[CI]:1.17-1.29,P 趋势<0.001)。同期,PPM 植入从 9.5%增加到 13.7%(每年调整后的 OR:1.22;95% CI:1.16-1.28,P 趋势<0.001)。与无 CHB 的患者相比,有 CHB 的患者住院死亡率更高(5.9% vs. 4.2%,调整后的 OR:1.32;95% CI:1.12-1.56;p=0.001)。此外,CHB 还与住院时间(LOS)延长和住院费用增加相关。
在研究期间,CHB 和 PPM 植入率显著增加。CHB 的发生与住院死亡率、LOS 和住院费用增加有关。